Literature DB >> 2185697

Fibrotic skin diseases. Clinical presentations, etiologic considerations, and treatment options.

J Uitto1, S Jimenez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2185697     DOI： 10.1001/archderm.126.5.661

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  6 in total

1.  Outgrowth of fibroblast cells from goat skin explants in three different culture media and the establishment of cell lines.

Authors:  Mahipal Singh; Anil K Sharma
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-11-25       Impact factor: 2.416

Review 2.  Engineered Biomaterial Platforms to Study Fibrosis.

Authors:  Matthew D Davidson; Jason A Burdick; Rebecca G Wells
Journal:  Adv Healthc Mater       Date:  2020-03-17       Impact factor: 9.933

Review 3.  The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets.

Authors:  Julie K Nguyen; Evan Austin; Alisen Huang; Andrew Mamalis; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2019-09-06       Impact factor: 3.017

Review 4.  Notch-ing up knowledge on molecular mechanisms of skin fibrosis: focus on the multifaceted Notch signalling pathway.

Authors:  Angelo Giuseppe Condorelli; May El Hachem; Giovanna Zambruno; Alexander Nystrom; Eleonora Candi; Daniele Castiglia
Journal:  J Biomed Sci       Date:  2021-05-09       Impact factor: 8.410

Review 5.  Mesenchymal stem cells in fibrotic diseases-the two sides of the same coin.

Authors:  Lei Qin; Nian Liu; Chao-le-Meng Bao; Da-Zhi Yang; Gui-Xing Ma; Wei-Hong Yi; Guo-Zhi Xiao; Hui-Ling Cao
Journal:  Acta Pharmacol Sin       Date:  2022-07-27       Impact factor: 7.169

Review 6.  Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa.

Authors:  Grace Tartaglia; Qingqing Cao; Zachary M Padron; Andrew P South
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.